The promise of molecular diagnostics for cancer prevention in terms of early detection rests on two premises: assays can be developed to measure proteins, DNA, RNA or metabolites that accurately and reproducibly detect incipient neoplasias; and that this early detection will eventually result in a ...
Biomarkers in Breast Cancer Molecular Diagnostics for Predicting and Monitoring Therapeutic Effect. Totowa: Humana Press;... D Kandioler,R Jakesz - Humana Press 被引量: 6发表: 2006年 Cancer Drug Discovery and Development: Biomarkers in Breast Cancer: CANCER DRUG DISCOVERY AND DEVELOPMENTCANCER DRUG...
Molecular Diagnostics of Cancer Edited by Pier Paolo Piccaluga Book metrics overview 1,430 Chapter Downloads View Full Metrics Academic Editor Pier Paolo Piccaluga University of Bologna,Italy Published10 April 2024 Doi10.5772/intechopen.111118 ISBN978-1-83769-433-4 Print ISBN978-1-83769-434-1 eB...
Molecular Diagnostics of Cancer 作者: Neumann, Siegfried 编 页数: 223定价: $ 141.25ISBN: 9783540554769豆瓣评分 目前无人评价 评价: 写笔记 写书评 加入购书单 分享到 推荐 我来说两句 短评 ··· 热门 还没人写过短评呢 我要写书评 Molecular Diagnostics of Cancer的书评 ··· ( 全部0 条 ) ...
当当中华商务进口图书旗舰店在线销售正版《海外直订医药图书Molecular Diagnostics of Cancer 癌症的分子诊断》。最新《海外直订医药图书Molecular Diagnostics of Cancer 癌症的分子诊断》简介、书评、试读、价格、图片等相关信息,尽在DangDang.com,网购《海外直订医药图
Molecular Diagnostics and Treatment of Pancreatic Cancer Pancreatic cancer is a malignant disease relating to uncontrollable cell growth in the tissues of the pancreas. The vast majority of pancreatic cancers are... AS Azmi - 《Anticancer Research》 被引量: 1发表: 2015年 Clinical relevance of mole...
Molecular diagnostics of cancer predisposition: hereditary non-polyposis colorectal carcinoma and mismatch repair defects Hereditary non-polyposis colorectal carcinoma accounts for 5-13% of all colorectal carcinomas and is inherited in a dominant fashion. Two different forms c... T Bocker,J Rüschoff,...
Dec 19, 2024 | Molecular Diagnostics Adding genetic testing to the evaluation of children with neurodevelopmental disorders leads to better-tailored care. Read More New Blood Test Predicts Prognosis for Advanced Prostate Cancer Patients Dec 11, 2024 | Molecular Diagnostics, Prostate The AR-ctDETEC...
Theglobal molecular diagnostics marketfor cancer care was valued at $1.6 billion last year, up more than 10 percent from 2018. That’s just a fraction of the entire molecular diagnostics field, but still staggering for a medical arena that’s still in its infancy. ...
and the rate of the approval of targeted cancer therapies remains woefully low. A key challenge and priority in cancer research is therefore to identify molecular biomarkers that could be used to improve early diagnosis, as well as to guide prognosis and the design and monitoring of new therapeut...